Meteora Capital’s Envoy Medical COCH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.2K Hold
2,805
– – ﹤0.01% 336
2026
Q1
$18.7K Hold
2,805
– – ﹤0.01% 297
2025
Q4
$18.5K Buy
2,805
+68
+2% +$538 ﹤0.01% 284
2025
Q3
$21.2K Buy
+2,737
New +$37.1K ﹤0.01% 238
2024
Q1
– Sell
-42,561
Closed -$771K – 280
2023
Q4
$771K Hold
42,561
– – 0.13% 132
2023
Q3
$2.99M Buy
42,561
+14,083
+49% +$1.41M 0.51% 54
2023
Q2
$2.92M Sell
28,478
-12,000
-30% -$1.21M 0.54% 57
2023
Q1
$4.07M Buy
+40,478
New +$4.06M 0.48% 65

Other funds holding COCH

Meteora Capital's COCH Position: Q2 2026 in Review

Meteora Capital held its Envoy Medical (COCH) position steady in Q2 2026 at 2,805 shares worth $22.2K. The position accounts for ﹤0.01% of the portfolio, ranked #336.

Meteora Capital first reported a position in COCH in Q1 2023 and has held it in 8 quarters since. The position peaked at $4.07M in Q1 2023. 31 funds tracked by Wall St. Rank hold COCH as of Q2 2026.

  • Meteora Capital held 2,805 shares of Envoy Medical worth $22.2K as of Q2 2026.
  • Meteora Capital left its Envoy Medical share count unchanged in Q2 2026.
  • Envoy Medical made up ﹤0.01% of Meteora Capital's portfolio in Q2 2026, its #336 holding.
  • Meteora Capital first reported a position in Envoy Medical in Q1 2023 and has held it in 8 quarters since.
  • Meteora Capital's Envoy Medical position peaked at $4.07M in Q1 2023.
  • 31 funds tracked by Wall St. Rank held Envoy Medical as of Q2 2026.

Based on Meteora Capital's 13F filing for Q2 2026, filed 14 Aug 2026.